De novo design and bioactivity prediction of mitotic kinesin Eg5 inhibitors using MPNN and LSTM-based transfer learning. - Damilola S. Bodun; Isiaka O. Ibrahim; Mujeebat Bashiru; Rachael Oluwakamiye Abolade; Wilberforce K. Ndarawit; Adedoyin John-Joy Owolade; Temitope A. Ogunnupebi; Ibeh John Somtochukwu; Ezekiel A. Olugbogi; Katukoliya Gamage Anuththara Samadhi; Gbolahan O. Oduselu; Suliman Sharif; et al. (Comput. Biol. Medicine, 2025)